Table 1. Patient, donor, and graft... | American Society of Hematology

Table 1.

Patient, donor, and graft characteristics

No. patients

116^*

Median patient age (range)

38 yrs (17-61)

Patient sex (male/female)

58/58

Diagnosis

Leukemia/myelodysplastic syndrome

66

Lymphoma/Hodgkin disease/myeloma

42

Solid tumor

8

Disease status

First remission or chronic phase

12

Second remission or accelerated phase

31

Relapse or blast crisis

73

Preparative regimen

Total body irradiation–based

30

Chemotherapy alone

86

GVHD prophylaxis

Cyclosporine/methylprednisolone

32

Tacrolimus/methylprednisolone

45

Tacrolimus/methotrexate

39

Prior grades 2-4 acute GVHD

33

On steroids at day 100

46

Median donor age (range)

39 yrs (8-64)

Donor sex (male/female)

57/59

Pair cytomegalovirus-seronegative

12

Total nucleated cells infused (range)

8.7 × 10⁸/kg (1.1-26.3)

CD34⁺ cells infused (range)

5.7 × 10⁶/kg (1.9-20.9)

CD3⁺ cells infused (range)

2.3 × 10⁸/kg (0.3-6.9)

CD56⁺cells infused (range)

2.6 × 10⁷/kg (1.0-8.1)

No. patients unless indicated otherwise.